22 dec: BICHELS WEEKENDHAPSERE - OGSÅ I JULEN
23 dec: Top 3 på teamudvikling
22-12-2010 16:57:00

Briscoe Law Firm Investigates Martek Biosciences for Shareholders

The

Briscoe Law Firm, PLLC, founded by a former state prosecutor and

enforcement attorney for the United States Securities and Exchange

Commission, and the law firm of Powers

Taylor LLP are investigating the fairness of the proposed

acquisition of Martek

Biosciences Corporation (“Martek Biosciences” or “MATK”) (NASDAQ:

MATK) by Royal DSM N.V. (“DSM”) for shareholders. The investigation

relates to possible breaches of fiduciary duty and other violations of

state law by the Board of Directors of Martek Biosciences for approving

this transaction, whether Martek Biosciences’ Board of Directors acted

in the shareholders’ best interests, and whether the transaction

provides fair value and adequate disclosures to the shareholders.

The definitive acquisition agreement, which was announced on December

21, 2010, involves an all-cash tender offer valued at approximately

$1.09 billion that is expected to commence in January 2011 and close in

February 2011. Under the proposed acquisition, Martek Biosciences

shareholders will receive a cash payment of only $31.50 for each share

of Martek Biosciences/MATK common stock they hold. While the acquisition

price reportedly represents an approximate 35% premium over Martek

Biosciences’ closing price the day before the acquisition announcement,

Martek Biosciences recently reported strong fourth quarter results,

including a 36% increase in revenue growth, well above analysts’

estimates, and operational improvements. Based on this and other

factors, the firms believe that the acquisition price significantly

undervalues the company and may not be fair to Martek Biosciences

shareholders.

If you currently own shares of Martek Biosciences/MATK and would like

additional information regarding this investigation, or if you have

information regarding the allegations involved in this transaction,

please contact Patrick Powers at Powers Taylor LLP, toll free (877)

728-9607, via e-mail at patrick@powerstaylor.com,

or Willie Briscoe at The Briscoe Law Firm, PLLC toll free (877)

397-5991, or via email at WBriscoe@TheBriscoeLawFirm.com.

There is no cost or fee to you.

The Briscoe Law Firm is a full service business litigation and

shareholder rights advocacy firm with more than 20 years of experience

in complex litigation and transactional matters.

Powers Taylor LLP is a boutique litigation law firm that handles a

variety of complex business litigation matters, including claims of

investor and stockholder fraud, shareholder oppression, shareholder

derivative suits, and security class actions.

Powers Taylor LLP

Patrick Powers, 877-728-9607

patrick@powerstaylor.com

or

The

Briscoe Law Firm, PLLC

Willie Briscoe, 877-397-5991

WBriscoe@TheBriscoeLawFirm.com

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
22 feb
BAVA
Tak for den dybe analyse, meget brugbart. Jeg har fluks solgt 8400 stk. på din fine anbefaling.   Af..
20
24 feb
CBRAIN
  I går kom cBrain med årsregnskab for 2016.   Jeg opdaterede senest min analyse af selskabet efter ..
17
24 feb
BAVA
For pokker hvor er de ved at gøre klar til at kører stærk hen over sommeren - Hvis vi lige kikker på..
16
23 feb
NOVO-B
Det er rygtes til USA, at Invertor1 er blevet fyret, og at der nu kun ansættes forstandige folk igen..
14
20 feb
BAVA
Der er såmænd nok ikke så mange herinde, der har en profession, der gør os til eskperter - og da sle..
14
18 feb
OMXC25
tonnio: Jeg er ikke i tvivl om, at et meget stort flertal af danskerne ville have stemt ja, til at v..
14
23 feb
BEO-SDB
Hej med Jer,   Jeg må meddele at jeg har haft taget fejl.   I udredningen fra Åsa er det tydeligt at..
12
20 feb
 
yep ... barack Obama tilbage på posten .. er man tilhænger af det - stik mig et point 
12
24 feb
FING-B
Kursen .... 800 k aktier ....   Nu er det jo ikke for at opildne til konspirationsteorier o.s.v. .....
11
23 feb
ONXEO
Jeg ved godt, at jeg taler for døve øren, og at du ikke på nogen måde har tænkt dig at stoppe med at..
11

Rovsing mindsker driftsunderskud i første halvår og opjusterer

24-02-2017 16:36:15
Omsætningen i Rovsing, der har hovedkontor i Skovlunde ved København og blandt andet producerer testsystemer til satellitter og elektroniske produkter til rumin..

KORR. Genmab/Sydbank: Positiv anbefaling er godt nyt - og ventet

24-02-2017 14:04:12
(Korr: "uger" rettet til "måneder" i sjette afsnit)Det europæiske lægemiddelagenturs (EMA) komite for medicinske produkter for human anvendelse (CHMP) har givet..

Aktier/middag: Mærsk og Genmab i C20-bunden og dukkert til Rockwool

24-02-2017 11:44:51
Trods yderligere fremgang til ISS, der torsdag leverede et stærkt regnskab, ligger det danske aktiemarked fredag middag i et minus efter fald i aktier som Mærsk..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2017  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
25. februar 2017 21:31:10
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20170217.2 - EUROWEB3 - 2017-02-25 21:31:10 - 2017-02-25 21:31:10 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x